Cardiac Diseases During Systemic Inflammatory Diseases in the Internal Medicine and Medical Oncology Department of NTHC-HKM of Cotonou

Abstract

Systemic inflammatory diseases are characterized by multivisceral involvement at some point in their evolution. This involvement can concern almost all organs, including the heart. Each systemic condition has a unique cardiac expression. The target of this study is to determine the frequency of cardiac involvement in systemic inflammatory diseases. This study is a cross-sectional, descriptive, and analytical study that was conducted within 07 months. The aim was to screen 23 patients followed for systemic inflammatory diseases for cardiac involvement. The mean age was 44 (±12) years old with a minimum of 24 and a maximum 64 years. Most of patients were women with a sex ratio (M/F) of 0.09. An echocardiographic abnormality was found in 26.1% of patients and 73.1% had an ECG abnormality. They included left atrial hypertrophy (43.4%), left ventricular hypertrophy (30.4%), right axial deviation (26.1%), low voltage (21.7%), right atrial hypertrophy (8.6%), S1Q3 appearance (8, 6%), pulmonary hypertension (8.6%), repolarization disorders (8.6%), sinus tachycardia (8.6%), middle tricuspid insufficiency (4.3%), middle pulmonary insufficiency (4.3%), and pericarditis (4.3%). Patients with systemic inflammatory diseases had cardiac disorders with rare clinical manifestations but with an incidental discovery either on ECG or on cardiac echodoppler. Hence, a systematic cardiac exploration in these patients was essential.